Table 2b.
Ethnic Group | Comparison | Estimate | SE | DF | T Value | Pr > |t| | Adjusteda p-value | |
---|---|---|---|---|---|---|---|---|
Hispanic (n= 71) | Moderate | Pronounced | 0.19 | 0.40 | 371 | 0.48 | 0.6295 | 0.6295 |
Moderate | Good | −0.94 | 0.89 | 371 | −1.06 | 0.2899 | 0.3382 | |
Moderate | Neutral | 0.24 | 0.54 | 371 | 0.44 | 0.6604 | 0.6604 | |
Pronounced | Good | −1.14 | 0.91 | 371 | −1.25 | 0.2128 | 0.2929 | |
Pronounced | Neutral | 0.04 | 0.58 | 371 | 0.08 | 0.9387 | 0.9387 | |
Good | Neutral | 1.18 | 0.98 | 371 | 1.20 | 0.2301 | 0.2929 | |
Black (n= 89) | Moderate | Pronounced | 0.87 | 0.36 | 371 | 2.42 | 0.0158 | 0.0553 |
Moderate | Good | −0.66 | 0.50 | 371 | −1.34 | 0.1820 | 0.2831 | |
Moderate | Neutral | 0.88 | 0.60 | 371 | 1.47 | 0.1416 | 0.2831 | |
Pronounced | Good | −1.52 | 0.52 | 371 | −2.92 | 0.0037 | 0.0259 | |
Pronounced | Neutral | 0.01 | 0.62 | 371 | 0.02 | 0.9816 | 0.9816 | |
Good | Neutral | 1.54 | 0.71 | 371 | 2.17 | 0.0306 | 0.0714 | |
White (n= 227) | Moderate | Pronounced | −0.32 | 0.24 | 371 | −1.37 | 0.1711 | 0.2831 |
Moderate | Good | −1.11 | 0.26 | 371 | −4.21 | <.0001 | 0.0001 | |
Moderate | Neutral | −0.14 | 0.38 | 371 | −0.38 | 0.7069 | 0.7069 | |
Pronounced | Good | −0.79 | 0.29 | 371 | −2.71 | 0.0070 | 0.0327 | |
Pronounced | Neutral | 0.18 | 0.40 | 371 | 0.45 | 0.6553 | 0.6553 | |
Good | Neutral | 0.97 | 0.42 | 371 | 2.31 | 0.0214 | 0.0599 |
LS means adjusted for age, subjective numeracy, current use of a disease modifying medication, and patient global assessment of disease activity; p-values are corrected for multiplicity.